Diabetic macular oedema: a prospective randomised trial of management with intravitreal bevacizumab (Avastin) versus conventional laser therapy in diabetic macula oedema.
Phase of Trial: Phase IV
Latest Information Update: 06 Nov 2012
At a glance
- Drugs Bevacizumab (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- Acronyms BOLT
- 01 Aug 2012 2-Year results published in the Archives of Ophthalmology (Report 3).
- 05 Jan 2009 Status is completed, as reported by ISRCTN: Current Controlled Trials.
- 13 Aug 2007 New trial record.